Utah Medical Products Inc. said its subsidiary Femcare Ltd. will acquire Orion Medical Supplies Ltd., a British manufacturer and distributor of medical devices aimed at reducing harm from blood-borne viruses among high-risk populations, for £3.6 million in cash.
The deal, expected to add approximately $6 million to Utah Medical’s consolidated annual sales, follows the retirement of Orion’s former owners. Femcare plans to integrate Orion’s operations into its facilities in Romsey, UK, after a transition period, with the primary financial benefit anticipated from lower operational costs as a percentage of UK sales.
Orion, which has operated as a private company in the UK since 2008, assembles and distributes devices accepted by the UK National Health Service and other European organizations. While the acquired products do not directly overlap with Femcare’s existing portfolio, the company cited growth potential in the specialized niche market and the ability to leverage existing customer distribution channels.
Utah Medical, listed on the NASDAQ under the ticker UTMD, expects to disclose additional risk factors related to the acquisition in its Form 10-Q filing for the third quarter of 2026, due by October 15. The company’s stock was down 2.25% at the time of the announcement.
Kevin Cornwell, CEO of Utah Medical, described the acquisition as fitting the company’s strategy: a stable, profitable, and accessible business with well-accepted products in a specialized niche with growth potential where customer distribution can be enhanced.
